SUBJECTS : Blood Disorders | Blood Diseases | Haematolog
Therapeutic Advances in Hematology: 2023, vol: 14, issue:
- 1)- Cedric Hermans, Yves Gruel, Laurent Frenzel, Evelien Krumb. How to translate and implement the current science of gene therapy into haemophilia care? Therapeutic advances in hematology. 2023, 14: 20406207221145627
Cited : 8Read More - 2)- Alessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, Marco Ruggeri, Sergio Siragusa, Nicola Vianelli, Francesco Zaja, Francesco Rodeghiero. Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion. Therapeutic advances in hematology. 2023, 14: 20406207221147777Cited : 2Read More
- 3)- Zhe Li, Wei Mu, Min Xiao. Genetic lesions and targeted therapy in Hodgkin lymphoma. Therapeutic advances in hematology. 2023, 14: 20406207221149245Cited : 1Read More
- 4)- Ehab Atallah, Lovneet Saini, Rodrigo Maegawa, Tanvi Rajput, Regina Corbin, Ricardo Viana. Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review. Therapeutic advances in hematology. 2023, 14: 20406207221150305Cited : 2Read More
- 5)- Fadi G Haddad, Jacki Sawyers, Nicholas J Short. Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Therapeutic advances in hematology. 2023, 14: 20406207231151294Cited : 7Read More
- 6)- Alexander Ngwube, Hemalatha Rangarajan, Niketa Shah. Role of abatacept in the prevention of graft--host disease: current perspectives. Therapeutic advances in hematology. 2023, 14: 20406207231152644Cited : 3Read More
- 7)- Lejun Huang, Jianxuan Xu, Huaying Zhang, Mengfan Wang, Yiyue Zhang, Qing Lin. Application and investigation of thrombopoiesis-stimulating agents in the treatment of thrombocytopenia. Therapeutic advances in hematology. 2023, 14: 20406207231152746Cited : 1Read More
- 8)- Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, Luisa Verga, Federico Itri, Zdeněk Ráčil, Julio Dávila-Valls, Sonia Martín-Pérez, Jaap Van Doesum, Francesco Passamonti, Ghaith Abu-Zeinah, Francesca Farina, Alberto López-García, Giulia Dragonetti, Chiara Cattaneo, Maria Gomes Da Silva, Yavuz M Bilgin, Pavel Žák, Verena Petzer, Andreas Glenthøj, Ildefonso Espigado, Caterina Buquicchio, Valentina Bonuomo, Lucia Prezioso, Stef Meers, Rafael Duarte, Rui Bergantim, Ozren Jaksic, Natasha Čolo. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry. Therapeutic advances in hematology. 2023, 14: 20406207231154706Cited : 3Read More
- 9)- Mahesh Swaminathan, Jorge E Cortes. Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia. Therapeutic advances in hematology. 2023, 14: 20406207231154708Cited : 16Read More
- 10)- Jae-Ho Yoon, Daehun Kwag, Jong-Hyuk Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee. Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis. Therapeutic advances in hematology. 2023, 14: 20406207231154713Cited : 2Read More
- 11)- Linchun Xu, Shaoze Lin, Xueyang Xing, Yongzhong Su. Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis. Therapeutic advances in hematology. 2023, 14: 20406207231155028Cited : 0Read More
- 12)- Panagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, Michalis Samarkos, Helen Gogas. Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature. Therapeutic advances in hematology. 2023, 14: 20406207231155991Cited : 0Read More
- 13)- Jan Astermark, Jan Blatný, Christoph Königs, Cédric Hermans, Victor Jiménez-Yuste, Daniel P Hart. Considerations for shared decision management in previously untreated patients with hemophilia A or B. Therapeutic advances in hematology. 2023, 14: 20406207231165857Cited : 6Read More
- 14)- Mark T Reding, Ingrid Pabinger, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso, Shadan Lalezari, Wolfgang Miesbach, Giovanni Di Minno, Robert Klamroth, Cedric Hermans. Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: analysis from the PROTECT VIII study. Therapeutic advances in hematology. 2023, 14: 20406207231166779Cited : 3Read More
- 15)- Meiru Bu, Xi Deng, Yu Zhang, Sean W Chen, Muliang Jiang, Bihong T Chen. Brain iron content and cognitive function in patients with β-thalassemia. Therapeutic advances in hematology. 2023, 14: 20406207231167050Cited : 2Read More
- 16)- Luis Carlos Saiz, Leire Leache, Marta Gutiérrez-Valencia, Juan Erviti, María Ximena Rojas Reyes. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies. Therapeutic advances in hematology. 2023, 14: 20406207231168211Cited : 0Read More
- 17)- Na Li, Jianying Lei, Jiahao Zhang, Hongfu Cai, Bin Zheng, Ting Yang, Maobai Liu, Jianda Hu. Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States. Therapeutic advances in hematology. 2023, 14: 20406207231168215Cited : 2Read More
- 18)- Xiaoyan Lv, Pengpeng Li, Pengpeng Yue, Ping Tang, Fuling Zhou. Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS. Therapeutic advances in hematology. 2023, 14: 20406207231170513Cited : 2Read More
- 19)- Jan Astermark, Cédric Hermans, Monia Ezzalfani, Alaeddine Sidhom, Sylvaine Barbier, Nana Kragh, Aletta Falk, Daniel Eriksson. Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: analysis of phase III trials using patient-reported outcomes. Therapeutic advances in hematology. 2023, 14: 20406207231170701Cited : 2Read More
- 20)- Hao Wang, Kristin N Berger, Elizabeth L Miller, Wei Fu, Larisa Broglie, Frederick D Goldman, Heiko Konig, Su Jin Lim, Arthur S Berg, Julie-An Talano, Melanie A Comito, Sherif S Farag, Jeffrey J Pu. The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. Therapeutic advances in hematology. 2023, 14: 20406207231170708Cited : 0Read More
- 21)- Catherine Broome. Efgartigimod alfa for the treatment of primary immune thrombocytopenia. Therapeutic advances in hematology. 2023, 14: 20406207231172831Cited : 4Read More
- 22)- Marcelo Lima Ribeiro, Salvador Sánchez Vinces, Laura Mondragon, Gael Roué. Epigenetic targets in B- and T-cell lymphomas: latest developments. Therapeutic advances in hematology. 2023, 14: 20406207231173485Cited : 0Read More
- 23)- Wojciech Jurczak, Nagah Elmusharaf, Christopher P Fox, William Townsend, Amanda G Paulovich, Jeffrey R Whiteaker, Fanny Krantz, Chuan-Chuan Wun, Graeme Parr, Shringi Sharma, Veerendra Munugalavadla, Richa Manwani, Emma Dean, Talha Munir. Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia. Therapeutic advances in hematology. 2023, 14: 20406207231173489Cited : 2Read More
- 24)- Zachary D Crees, Michael P Rettig, John F DiPersio. Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide. Therapeutic advances in hematology. 2023, 14: 20406207231174304Cited : 7Read More
- 25)- Helen O Ajufo, Julian A Waksal, John O Mascarenhas, Raajit K Rampal. Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges. Therapeutic advances in hematology. 2023, 14: 20406207231177282Cited : 3Read More
- 26)- Carmen Escuriola-Ettingshausen, Robert Klamroth, Miguel Escobar, Oleksandra Stasyshyn, Srilatha Tangada, Werner Engl, Ivan Honauer, Hye-Youn Lee, Pratima Chowdary, Jerzy Windyga. Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: subanalysis of the randomized, phase 3 PROPEL study. Therapeutic advances in hematology. 2023, 14: 20406207231178596Cited : 0Read More
- 27)- Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, Ming-Sun Yu, Shih-Hao Huang, Alex Jia-Hong Lin, Kuan-Der Lee, Min-Chi Chen. Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study. Therapeutic advances in hematology. 2023, 14: 20406207231179331Cited : 1Read More
- 28)- Yufeng Wang, Xiaoyue Chu, Xihui Chen, Anan Yin, Yan Yao, Li Wang, Hua Xu, Fangfang Liu, Kun Chen, Yuanming Wu. Non-invasive prenatal testing for fetal Ss, Kidd, and CTL2 blood group prediction by multiplex digital droplet PCR. Therapeutic advances in hematology. 2023, 14: 20406207231179334Cited : 0Read More
- 29)- Abiola Oladapo, Scott Kolodny, Michael Vredenburg, Elyse Swallow, Debbie Goldschmidt, Kirthana Sarathy, Priscilla Lopez, Hillary Maitland, John Yee. Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study. Therapeutic advances in hematology. 2023, 14: 20406207231179856Cited : 1Read More
- 30)- Xiaoying Zhang, Xingcheng Yang, Ling Ma, Yicheng Zhang, Jia Wei. Immune dysregulation and potential targeted therapy in myelodysplastic syndrome. Therapeutic advances in hematology. 2023, 14: 20406207231183330Cited : 3Read More
- 31)- Manfred Welslau, Boris Kubuschok, Julian Topaly, Burkhard Otremba, Thomas Wolff, Galyna Bryn. REFLECT: prospective multicenter non-interventional study evaluating the effectiveness and safety of Sandoz rituximab (SDZ-RTX; Rixathon) in combination with CHOP for the treatment of patients with previously untreated CD20-positive diffuse large B-cell lymphoma. Therapeutic advances in hematology. 2023, 14: 20406207231183765Cited : 1Read More
- 32)- Carmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, Ana R Cid, Kate Khair, Johannes Oldenburg, Claude Négrier, Jaco Botha, Aurelia Lelli, Jerzy Windyga. Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study. Therapeutic advances in hematology. 2023, 14: 20406207231184323Cited : 2Read More
- 33)- Congyuan He, Linshen Xie, Lingxi Gu, Hongyu Yan, Shiyu Feng, Chunmei Zeng, Wangjiu Danzhen, Xuehui Zhang, Mingming Han, Zhifeng Li, Zhuoma Duoji, Bing Guo, Juying Zhang, Feng Hong, Xing Zhao. Anemia is associated with long-term exposure to PM and its components: a large population-based study in Southwest China. Therapeutic advances in hematology. 2023, 14: 20406207231189922Cited : 3Read More
- 34)- Marianna De Muro, Annelot Julia Janssen, Sergio Amadori, Paolo de Fabritiis, Dante Sabatino, Pasquale Niscola, Lorenza Torti, Malgorzata Monika Trawinska, Cristiano Tesei, Felice Bombaci, Mario Tarricone, Monica Bocchia, Carmen Fava, Sara Galimberti, Alessandra Iurlo, Luigia Luciano, Elisabetta Abruzzese. Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy. Therapeutic advances in hematology. 2023, 14: 20406207231190683Cited : 0Read More
- 35)- Zhuxin Zhang, Qinglin Hu, Chen Yang, Miao Chen, Bing Han. Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China. Therapeutic advances in hematology. 2023, 14: 20406207231191310Cited : 3Read More
- 36)- Arpita P Gandhi, Laura F Newell, Richard T Maziarz. A new beginning: can omidubicel emerge as the next, viable alternative donor source? Therapeutic advances in hematology. 2023, 14: 20406207231192146Cited : 1Read More
- 37)- Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Antonis Kattamis, Kevin H M Kuo, Ali T Taher. Luspatercept for transfusion-dependent β-thalassemia: time to get real. Therapeutic advances in hematology. 2023, 14: 20406207231195594Cited : 0Read More
- 38)- Léa Schmitz, Michelle Pirotte, Alizée Lebeau, Marie Ernst, Marianne Fillet, Anais Devey, Justine Schmitt, Gaël Cobraiville, Marilène Binsfeld, Stéphanie Gofflot, Yves Beguin, Gaëlle Vertenoeil. Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic advances in hematology. 2023, 14: 20406207231199837Cited : 1Read More
- 39)- Hagop M Kantarjian, Aaron C Logan, Faraz Zaman, Nicola Gökbuget, Ralf C Bargou, Yi Zeng, Gerhard Zugmaier, Franco Locatelli. Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab. Therapeutic advances in hematology. 2023, 14: 20406207231201454Cited : 1Read More
- 40)- Fieke W Hoff, John Rolwes, Paula A Hardeman, Molly Perkins, Eugene O Major, Daniel Douek, Robert H Collins, Benjamin M Greenberg. Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report. Therapeutic advances in hematology. 2023, 14: 20406207231201721Cited : 1Read More
- 41)- Jan Astermark, Fariba Baghaei, Karin Strandberg, Petra Gabric Toplican, Maj Friberg Birkedal, Emma Engman Grahn, Charlotta Hansson, Peter Kampmann, Anna-Elina Lehtinen, Kinga Täckström, Pål Andre Holme, Maria Magnusson. Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context. Therapeutic advances in hematology. 2023, 14: 20406207231202306Cited : 0Read More
- 42)- Ling Xue, Lin Song, Xun Yu, Xiao Yang, Fan Xia, Xiaoliang Ding, Chenrong Huang, Depei Wu, Liyan Miao. Assessment of risk factors for acute graft--host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effects model. Therapeutic advances in hematology. 2023, 14: 20406207231205406Cited : 0Read More
- 43)- Robert Briski, Guillermo Garcia-Manero, Hagop Kantarjian, Farhad Ravandi. The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia. Therapeutic advances in hematology. 2023, 14: 20406207231205429Cited : 3Read More
- 44)- David J Kuter, James B Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P Lambert, Howard A Liebman, Michael D Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak. Rilzabrutinib placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study. Therapeutic advances in hematology. 2023, 14: 20406207231205431Cited : 5Read More
- 45)- Hyunkyung Park, Hyeong-Joon Kim, Sang-Kyun Sohn, Yoonsuk Baik, Dongho Kim, Sung-Yeoun Lee, Jee Hyun Kong, Hawk Kim, Dong-Yeop Shin, Jae-Sook Ahn, Jinny Park, Seonyang Park, Inho Kim. Effect of transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor. Therapeutic advances in hematology. 2023, 14: 20406207231205637Cited : 1Read More
- 46)- Francesco Mannelli, Francesca Crupi, Roberta Zanotti, Livio Pagano, Davide Rapezzi, Ilaria Tanasi, Marianna Criscuolo, Massimiliano Bonifacio, Alberto Fresa, Paola Guglielmelli, Alessandro M Vannucchi. The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Therapeutic advances in hematology. 2023, 14: 20406207231205643Cited : 1Read More
- 47)- Zaijing Fan, Lihong Shou. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis. Therapeutic advances in hematology. 2023, 14: 20406207231208973Cited : 1Read More
- 48)- Ru Feng, Shuai Zhang, Jiang-Tao Li, Ting Wang, Chun-Li Zhang, Jie-Fei Bai, Lei Yang, Li-Ru Wang, Hong-Mei Jing, Hui Liu. Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65 years or older: a prospective study based on comprehensive geriatric assessment. Therapeutic advances in hematology. 2023, 14: 20406207231208979Cited : 1Read More
- 49)- Domenico Russo, Michele Malagola, Nicola Polverelli, Mirko Farina, Federica Re, Simona Bernardi. Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient. Therapeutic advances in hematology. 2023, 14: 20406207231216077Cited : 1Read More
- 50)- Jiyeon Lee, Haeseon Lee, Siin Kim, Hae Sun Suh. Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis. Therapeutic advances in hematology. 2023, 14: 20406207231216080Cited : 0Read More
